Monday, April 11, 2022 Daily Archives

Moderna recalls another lot of COVID-19 vax

by

Moderna has recalled one lot of its COVID-19 vaccine, Spikevax, after a foreign body was found in a vial produced by CDMO Rovi.   Moderna and Spanish contract development manufacturing organization (CDMO) Laboratorios Farmacéuticos Rovi jointly announced that they have recalled lot #000190A of Spikevax in Europe, which consisted of 764,900 doses. The firms were made aware of the issue through a product complaint from a vaccination center based in Malaga, Spain. The dose in question was returned for forensic…

April 11, 2022

MAST away: Lonza sells bioreactor sampling tech to MilliporeSigma

by

MilliporeSigma says the addition of the MAST (Modular Automated Sampling Technology) platform will help its customers optimize their bioprocesses and speed up development time. Lonza is offloading the platform to bioprocess vendor and fellow contract manufacturer MilliporeSigma – the life sciences service division of Germany’s Merck – for an undisclosed fee. The technology provides biomanufacturers near real-time sampling and analysis of bioreactors, the results of which can be used to deliver a range of analytical devices measuring titer, metabolites, and…

April 11, 2022

Trade secrets theft: ‘Unfair to the innovator, unfair to the industry’

by

Two co-founders of Taiwanese firm JHL Biotech were sentenced last month for plotting to steal trade secrets from Genentech and commit wire fraud exceeding $101 million. BioProcess Insider spoke to the attorneys who represented Genentech in this landmark civil and criminal case. According to the suit, the story goes back thirteen years where former principal scientist Xanthe Lam and her husband, Allen Lam, conspired to commit stealing trade secrets from Genentech and passing the information to Taiwanese company JHL Biotech (now Eden…

April 11, 2022

GSK site revamp reportedly on ropes; PE blames lack of Gov commitment

by

After receiving permission to build a £350 million biomanufacturing facility at a former GSK site in Ulverston, UK last year, Lakes BioSciences’ plan has reportedly fallen through. In February 2021, contact development manufacturing organization (CDMO) Lakes BioScience was granted permission from South Lakeland District to build a facility on GlaxoSmithKline’s (GSK) site located on North Lonsdale Road, Ulverston, Cumbria. Lakes BioScience director, Pat McIver told BioProcess Insider at the time that £350 million ($490 million) was being invested to build a monoclonal…

April 11, 2022